RHO and hepatocellular carcinoma: Furthermore, Rho and ROCK activators suppressed the endothelial junctions and pericyte recruitment activity of BMP9‐overexpressing HBV‐infected hepatoma cells in vitro (Figure 5G,H, Supporting Information Figure S5A‐F).